Ship Healthcare Holdings (3360) AI Stock Analysis

• Market Cap: ¥179.02B
• Dividend Yield: 2.82%
• Average Volume (3M): 330.78K
• Price to Earnings (P/E): 12.8
• Beta (1Y): 0.47
• Revenue Growth: 7.49%
• EPS Growth: 9.71%
• Country: JP
• Employees: 7,793
• Sector: Healthcare
• Sector Strength: 40
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 48.86
• Shares Outstanding: 94,350,136
• 10 Day Avg. Volume: 346,660
• 30 Day Avg. Volume: 330,776
• PEG Ratio: -1.12
• Price to Book (P/B): 1.30
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥3,083.32
• Price Target Upside: 51.22% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 76 Outperform
• Price Target: ¥2,213.00 ▲(8.53%Upside)

Ship Healthcare Holdings has a solid overall stock score driven by strong financial performance and favorable technical indicators. The valuation also supports the score, with a reasonable P/E ratio and a good dividend yield. The exclusion of the earnings call and corporate events results in a more weighted focus on these aspects.

Ship Healthcare Holdings Business Overview & Revenue Model

Company Description

Ship Healthcare Holdings, Inc. engages in the medical, healthcare, welfare, and nursing care businesses worldwide. It operates through four segments: Total Pack Produce Business, Medical Supply Business, Lifecare Business, and Dispensing Pharmacy Business. The Total Pack Produce segment engages in sale of medical devices and medical equipment based on bulk orders; offers consulting services on medicine, healthcare, welfare, and nursing care facilities; and leasing of real estate to medical facilities and other tenants. The Medical Supply segment sells medical examination and treatment materials, and special treatment materials. The Life Care segment operates homes for senior citizens, group homes, and other facilities and nutritional services. The Dispensing Pharmacy segment operates dispensing pharmacies. The company was incorporated in 1992 and is headquartered in Suita, Japan.

How the Company Makes Money

Ship Healthcare Holdings generates revenue through multiple streams within the healthcare industry. The company earns income from the sale and leasing of medical equipment to hospitals and healthcare facilities, which forms a significant portion of its revenue. Additionally, the company provides hospital management services, including facility management and operational consulting, which contributes to its earnings. Ship Healthcare Holdings also engages in construction and renovation projects for healthcare facilities, further diversifying its revenue. Key partnerships with medical institutions and technology providers enhance its service offerings and support revenue growth by leveraging collaborative ventures. These diversified offerings allow the company to sustain its financial performance in a dynamic healthcare market.

Ship Healthcare Holdings Financial Statement Overview

Summary

Ship Healthcare Holdings demonstrates strong financial performance with consistent revenue growth, stable profit margins, and effective cash flow management. The reduction in leverage and improved return on equity further enhance its financial stability, despite a slight decrease in cash reserves.

Income Statement

Ship Healthcare Holdings has demonstrated robust revenue growth over the years, with a notable increase from 514.35 billion yen in 2022 to 678.23 billion yen in 2025. The gross profit margin remains stable at around 10%, and the net profit margin improved to approximately 2.23% in 2025. EBIT and EBITDA margins have been consistent, contributing to overall profitability. The company's ability to grow revenue consistently highlights its strong market position and effective business strategy.

Balance Sheet

The balance sheet of Ship Healthcare Holdings shows a healthy equity position, with a debt-to-equity ratio improving from 0.61 in 2020 to 0.25 in 2025, indicating reduced leverage and risk. The equity ratio remains strong, reflecting financial stability. Return on equity has improved, suggesting efficient use of shareholder funds. However, the reduction in cash reserves over time and the presence of debt warrants ongoing monitoring.

Cash Flow

Operating cash flow remains strong, supporting the company's operational needs. Despite fluctuations, free cash flow has shown positive growth, with a notable increase from 8.96 billion yen in 2022 to 16.56 billion yen in 2025. The operating cash flow to net income ratio is favorable, indicating effective cash management. While capital expenditures are well-managed, continuous monitoring of financing activities is recommended.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	678.23B	630.99B	572.28B	514.35B	497.16B
Gross Profit	66.74B	65.61B	60.62B	53.64B	54.49B
EBITDA	32.19B	29.75B	28.61B	26.23B	26.30B
Net Income	15.13B	13.79B	12.06B	12.17B	12.28B
Balance Sheet
Total Assets	381.70B	386.82B	381.98B	335.07B	334.50B
Cash, Cash Equivalents and Short-Term Investments	77.50B	85.07B	83.94B	77.44B	77.26B
Total Debt	37.34B	57.93B	73.94B	61.22B	64.96B
Total Liabilities	231.42B	244.60B	250.86B	212.76B	219.40B
Stockholders Equity	149.08B	139.52B	128.04B	118.29B	111.44B
Cash Flow
Free Cash Flow	16.56B	28.09B	10.20B	8.96B	14.76B
Operating Cash Flow	20.38B	31.61B	14.11B	12.43B	19.77B
Investing Cash Flow	-4.03B	-7.20B	-6.77B	-3.87B	-19.29B
Financing Cash Flow	-24.62B	-20.48B	-1.02B	-8.84B	-10.46B

Ship Healthcare Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2039.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3360, the sentiment is Positive. The current price of 2039 is above the 20-day moving average (MA) of 1974.67, above the 50-day MA of 1932.02, and below the 200-day MA of 2050.13, indicating a bullish trend. The MACD of 34.40 indicates Negative momentum. The RSI at 67.78 is Neutral, neither overbought nor oversold. The STOCH value of 78.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3360.

Ship Healthcare Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3360	76 Outperform	¥179.02B	12.83	10.34%	2.82%	7.49%	9.71%
Sector *	52 Neutral	$7.39B	>-0.01	-63.86%	2.36%	16.15%	0.36%
HGYMF	―	$361.86M	57.19	1.87%	0.02%	―	―
6SN	―	€973.75M	28.32	4.78%	2.65%	―	―
5FA	―	€1.28B	40.21	2.07%	2.96%	―	―
PBHDF	―	$919.60M	16.23	6.55%	0.03%	―	―
7730	74 Outperform	¥116.89B	21.41		2.70%	5.82%	-20.09%

Ship Healthcare Holdings Corporate Events

Ship Healthcare Holdings Acquires Treasury Shares to Enhance Market Position

Ship Healthcare Holdings, Inc. has announced the acquisition of 260,000 treasury shares in June 2025, valued at approximately 500.6 million yen. This move is part of a broader strategy authorized by the Board of Directors to acquire up to 3.3 million shares, with a total potential expenditure of 5 billion yen, aimed at strengthening the company’s market position and optimizing shareholder value.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Announces Treasury Shares Cancellation

Ship Healthcare Holdings, Inc. has announced the cancellation of 7,319,266 treasury shares, representing 7.20% of its total shares, as part of a strategic move to optimize its capital structure. This cancellation, scheduled for June 30, 2025, will result in the company having no treasury shares, potentially enhancing shareholder value and improving financial metrics.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Announces Share Buyback Plan

Ship Healthcare Holdings has announced a plan to acquire up to 3,300,000 of its own shares, valued at up to 5 billion yen, as part of its medium-term management plan. This move aims to enhance shareholder returns, improve earnings per share, and achieve a targeted return on equity of 12%, reflecting the company’s strategic focus on balancing growth investments with shareholder returns.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Introduces Restricted Stock Compensation Plan

Ship Healthcare Holdings, Inc. has announced the adoption of a restricted stock compensation plan aimed at incentivizing its directors to enhance corporate value sustainably and align their interests with shareholders. This plan, which will be proposed at the upcoming General Meeting of Shareholders, involves granting restricted stocks to eligible directors, with a total annual limit of 35,000 shares or ¥60 million in compensation, separate from existing monetary compensation.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Announces Executive Personnel Changes

Ship Healthcare Holdings, Inc. announced changes in its executive personnel following a Board of Directors meeting. Hiroshi Yokoyama will be promoted to Executive Vice President, while Hisanori Fujioka will be appointed as a new Executive Officer. These changes are set to take effect on June 27, 2025, pending approval at the Ordinary General Meeting of Shareholders. The restructuring aims to strengthen the company’s leadership and enhance its strategic direction.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Announces Dividend Distribution Plan

Ship Healthcare Holdings, Inc. announced a resolution to distribute surplus dividends, with a basis date of March 31, 2025, which will be presented to shareholders in June. The company aims to maintain a dividend payout ratio of 30% or more, reflecting its commitment to returning profits while supporting business growth and strengthening management foundations.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

SHIP Healthcare Unveils ‘SHIP VISION 2030’ for Sustainable Growth

SHIP Healthcare Holdings has announced its new medium-term management plan, ‘SHIP VISION 2030’, which aims to enhance sustainable growth over the next five years. The plan focuses on optimizing group management resources and includes targets for sales growth, operating profit margin, and return on equity. The company plans to allocate significant funds for strategic investments and maintain a progressive dividend payout. Additionally, the plan emphasizes sustainability efforts, aiming to create value by addressing social issues and contributing to a well-being society.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Reports Stable Financial Growth for FY 2025

Ship Healthcare Holdings reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a 7.5% increase in net sales to ¥678,229 million and a 9.6% rise in profit attributable to owners of the parent. Despite a decrease in comprehensive income, the company improved its equity capital ratio to 39.1% and increased its annual dividend to ¥58.00 per share. These results indicate a stable financial performance and a commitment to shareholder returns, positioning the company favorably in the healthcare market.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.